LWMI
TWST icon

Legacy Wealth Management (Idaho)’s Twist Bioscience TWST Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26
Closed -$1.24K – 904
2026
Q1 		$1.24K Hold
26
– – ﹤0.01% 841
2025
Q4 		$825 Hold
26
– – ﹤0.01% 773
2025
Q3 		$732 Sell
26
-25
-49% -$757 ﹤0.01% 650
2025
Q2 		$1.88K Hold
51
– – ﹤0.01% 522
2025
Q1 		$2K Hold
51
– – ﹤0.01% 538
2024
Q4 		$2.67K Hold
51
– – ﹤0.01% 468
2024
Q3 		$2.17K Buy
+51
New +$2.43K ﹤0.01% 474

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s TWST Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 26 shares — an estimated $1.24K sold.

Legacy Wealth Management (Idaho) first reported a position in TWST in Q3 2024 and held it in 7 quarters. The position peaked at $2.67K in Q4 2024. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 26 Twist Bioscience shares in Q2 2026, an estimated $1.24K.
  • Legacy Wealth Management (Idaho) first reported a position in Twist Bioscience in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Twist Bioscience position peaked at $2.67K in Q4 2024.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.